Common medications in this category include: Semaglutide (Wegovy/Ozempic) Tirzepatide (Zepbound/Mounjaro) Liraglutide Metformin To qualify for same-day issuance, the FAA requires several conditions be met: A current, detailed clinical progress note from your treating physician that meets FAA specifications Hemoglobin A1c testing within the previous 90 days An A1c below diabetic thresholds (6.4% or lower) No significant medication side effects No episodes of hypoglycemia requiring assistance The FAA also requires observation periods before pilots may resume flying duties after starting or adjusting medication dosages
Nausea affects roughly 30 to 35 percent of people at this level, compared to about 15 percent at 0.5mg
Some researchers may require higher doses or longer cycles to achieve noticeable effects, though increasing beyond standard protocols should be approached cautiously
These experiences are often called "taste changes," but they may reflect several biological processes rather than a single taste disorder
This is research-planning context, not a personal dosing recommendation
It May Also Be Helping Your Heart If you take a GLP-1 medication (like Ozempic, Wegovy, or Zepbound) to help manage your weight or blood sugar and also have a heart rhythm condition called atrial fibrillation (Afib), a new study from UVA Health offers some encouraging news